AU2002333626B2 - 1-glyoxlylamide indolizines for treating cancer - Google Patents
1-glyoxlylamide indolizines for treating cancer Download PDFInfo
- Publication number
- AU2002333626B2 AU2002333626B2 AU2002333626A AU2002333626A AU2002333626B2 AU 2002333626 B2 AU2002333626 B2 AU 2002333626B2 AU 2002333626 A AU2002333626 A AU 2002333626A AU 2002333626 A AU2002333626 A AU 2002333626A AU 2002333626 B2 AU2002333626 B2 AU 2002333626B2
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- group
- unsubstituted
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32202001P | 2001-09-13 | 2001-09-13 | |
| US60/322,020 | 2001-09-13 | ||
| PCT/US2002/029154 WO2003022846A1 (en) | 2001-09-13 | 2002-09-13 | 1-glyoxlylamide indolizines for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002333626A1 AU2002333626A1 (en) | 2003-06-19 |
| AU2002333626B2 true AU2002333626B2 (en) | 2006-06-29 |
Family
ID=23253054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002333626A Ceased AU2002333626B2 (en) | 2001-09-13 | 2002-09-13 | 1-glyoxlylamide indolizines for treating cancer |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6861436B2 (https=) |
| EP (1) | EP1432709B8 (https=) |
| JP (1) | JP2005504795A (https=) |
| KR (1) | KR20040053125A (https=) |
| CN (1) | CN1568324A (https=) |
| AT (1) | ATE300542T1 (https=) |
| AU (1) | AU2002333626B2 (https=) |
| BR (1) | BR0212794A (https=) |
| CA (1) | CA2459886A1 (https=) |
| DE (1) | DE60205265T2 (https=) |
| ES (1) | ES2245747T3 (https=) |
| IL (1) | IL160810A0 (https=) |
| IS (1) | IS7176A (https=) |
| MX (1) | MXPA04002323A (https=) |
| NO (1) | NO20041035L (https=) |
| NZ (1) | NZ531700A (https=) |
| PT (1) | PT1432709E (https=) |
| WO (1) | WO2003022846A1 (https=) |
| ZA (1) | ZA200401996B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040053125A (ko) * | 2001-09-13 | 2004-06-23 | 신타 파마슈티칼스 코프. | 암 치료용 1-글리옥실일아미드 인돌리진 |
| US20040116462A1 (en) * | 2002-12-12 | 2004-06-17 | Mitsunori Ono | Indolizine compounds |
| AU2003267071A1 (en) * | 2002-09-13 | 2004-04-30 | Synta Pharmaceuticals Corp. | Synthesis of indolizines |
| DE10318611A1 (de) | 2003-04-24 | 2004-11-11 | Elbion Ag | 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika |
| WO2005099824A1 (en) * | 2004-03-30 | 2005-10-27 | Synta Pharmaceuticals, Corp. | 1-glyoxylamide indolizines for treating lung and ovarian cancer |
| GB0413605D0 (en) | 2004-06-17 | 2004-07-21 | Addex Pharmaceuticals Sa | Novel compounds |
| US20070293456A9 (en) * | 2004-12-30 | 2007-12-20 | Anthony Hayford | Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
| US20070155738A1 (en) * | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| BRPI0609802A2 (pt) * | 2005-05-20 | 2017-05-02 | Alantos Pharmaceuticals Holding Inc | composto, composição farmacêutica e uso de um composto |
| JP5536773B2 (ja) * | 2008-08-14 | 2014-07-02 | ベータ・ファーマ・カナダ・インコーポレイテッド | Ｅｐ４受容体アンタゴニストとしてのヘテロ環式アミド誘導体 |
| SG175390A1 (en) | 2009-04-29 | 2011-12-29 | Amarin Corp Plc | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| AR077428A1 (es) * | 2009-07-29 | 2011-08-24 | Sanofi Aventis | (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos |
| CN113603694B (zh) * | 2021-07-16 | 2022-07-22 | 浙江工业大学 | 一种1,2-二酮类化合物及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2287706A (en) | 1994-03-21 | 1995-09-27 | Fujisawa Pharmaceutical Co | Indolizine derivatives |
| FR2757166B1 (fr) * | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
| WO1998047507A1 (en) | 1997-04-24 | 1998-10-29 | Shionogi & Co., Ltd. | Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds |
| CN1302300A (zh) | 1998-05-21 | 2001-07-04 | 盐野义制药株式会社 | 吡咯并[1,2－b]哒嗪sPLA2抑制剂 |
| CA2346334A1 (en) | 1998-10-14 | 2000-04-20 | Shionogi & Co., Ltd. | Composition for treating or preventing ischemia reperfusion injury |
| US6461538B2 (en) * | 1999-12-16 | 2002-10-08 | Fuji Photo Film Co., Ltd. | Production process for indolizine compounds and their use in organic light-emitting devices |
| US20040116462A1 (en) * | 2002-12-12 | 2004-06-17 | Mitsunori Ono | Indolizine compounds |
| KR20040053125A (ko) * | 2001-09-13 | 2004-06-23 | 신타 파마슈티칼스 코프. | 암 치료용 1-글리옥실일아미드 인돌리진 |
-
2002
- 2002-09-13 KR KR10-2004-7003754A patent/KR20040053125A/ko not_active Withdrawn
- 2002-09-13 NZ NZ531700A patent/NZ531700A/en unknown
- 2002-09-13 IL IL16081002A patent/IL160810A0/xx unknown
- 2002-09-13 ES ES02798231T patent/ES2245747T3/es not_active Expired - Lifetime
- 2002-09-13 AT AT02798231T patent/ATE300542T1/de not_active IP Right Cessation
- 2002-09-13 US US10/244,088 patent/US6861436B2/en not_active Expired - Fee Related
- 2002-09-13 JP JP2003526921A patent/JP2005504795A/ja active Pending
- 2002-09-13 EP EP02798231A patent/EP1432709B8/en not_active Expired - Lifetime
- 2002-09-13 CA CA002459886A patent/CA2459886A1/en not_active Abandoned
- 2002-09-13 MX MXPA04002323A patent/MXPA04002323A/es unknown
- 2002-09-13 DE DE60205265T patent/DE60205265T2/de not_active Expired - Fee Related
- 2002-09-13 AU AU2002333626A patent/AU2002333626B2/en not_active Ceased
- 2002-09-13 CN CNA028202848A patent/CN1568324A/zh active Pending
- 2002-09-13 WO PCT/US2002/029154 patent/WO2003022846A1/en not_active Ceased
- 2002-09-13 BR BR0212794-6A patent/BR0212794A/pt not_active IP Right Cessation
- 2002-09-13 PT PT02798231T patent/PT1432709E/pt unknown
-
2004
- 2004-03-11 ZA ZA200401996A patent/ZA200401996B/xx unknown
- 2004-03-11 NO NO20041035A patent/NO20041035L/no not_active Application Discontinuation
- 2004-03-11 IS IS7176A patent/IS7176A/is unknown
- 2004-05-20 US US10/849,978 patent/US20040214850A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IS7176A (is) | 2004-03-11 |
| DE60205265D1 (de) | 2005-09-01 |
| EP1432709A1 (en) | 2004-06-30 |
| ATE300542T1 (de) | 2005-08-15 |
| BR0212794A (pt) | 2004-10-05 |
| PT1432709E (pt) | 2005-10-31 |
| DE60205265T2 (de) | 2006-03-30 |
| ES2245747T3 (es) | 2006-01-16 |
| CA2459886A1 (en) | 2003-03-20 |
| NZ531700A (en) | 2006-10-27 |
| EP1432709B8 (en) | 2005-11-02 |
| US20030153759A1 (en) | 2003-08-14 |
| IL160810A0 (en) | 2004-08-31 |
| MXPA04002323A (es) | 2005-04-08 |
| KR20040053125A (ko) | 2004-06-23 |
| JP2005504795A (ja) | 2005-02-17 |
| ZA200401996B (en) | 2005-05-31 |
| NO20041035L (no) | 2004-04-30 |
| HK1063322A1 (en) | 2004-12-24 |
| CN1568324A (zh) | 2005-01-19 |
| WO2003022846A1 (en) | 2003-03-20 |
| US20040214850A1 (en) | 2004-10-28 |
| EP1432709B1 (en) | 2005-07-27 |
| US6861436B2 (en) | 2005-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002323475B2 (en) | 2-aroylimidazole compounds for treating cancer | |
| AU2002333626B2 (en) | 1-glyoxlylamide indolizines for treating cancer | |
| US20080090842A1 (en) | Novel pyridyl cyanoguanidine compounds | |
| JP2018524365A (ja) | Ｉｒａｋ−４阻害剤としての置換アザ化合物 | |
| KR20150123894A (ko) | 히스톤 데메틸라아제의 저해제 | |
| RU2195453C2 (ru) | Цианогуанидины, способы их получения и фармацевтический препарат на их основе | |
| AU2002323474B2 (en) | 3-glyoxlylamideindoles for treating cancer | |
| AU2002333626A1 (en) | 1-glyoxlylamide indolizines for treating cancer | |
| JP2020502066A (ja) | キナーゼ阻害剤としての複素環式化合物 | |
| AU2002323474A1 (en) | 3-glyoxlylamideindoles for treating cancer | |
| JP2016508521A (ja) | 抗腫瘍剤としての三環式複素環 | |
| JP4349476B2 (ja) | 細胞増殖抑制剤としてのシアノグアニジン | |
| KR20010013158A (ko) | 세포 증식 억제제로서의 시아노구아니딘 | |
| RU2195451C2 (ru) | Цианогуанидины, способы их получения и фармацевтический препарат на их основе | |
| EP1598352A1 (en) | 1-Glyoxylamide indolizines for treating cancer | |
| HK1063322B (en) | 1-glyoxylamide indolizines for treating cancer | |
| HK1079507A (en) | 1-glyoxylamide indolizines for treating cancer | |
| WO2023168908A1 (zh) | 稠合的醌肟咪唑及其鎓衍生物与其制备和用途 | |
| KR20250097910A (ko) | 포스파티딜이노시톨 3-키나제의 신규 억제제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |